Commentary on the MID3 good practices paper

EMA MSWG Group, .; Manolis, E; Brogren, J; Cole, S; Pittaway-Hay, J; Nordmark, A; Karlsson, KE; EMA MSWG Group, .; Manolis, E; Brogren, J; Cole, S; Pittaway-Hay, J; Nordmark, A; Karlsson, KE; Lentz, F; Benda, N; Wangorsch, G; Pons, G; Zhao, W; Gigante, V; Serone, F; Standing, JF; Dokoumetzidis, A; Vakkilainen, J; van den Heuvel, M; Mangas Sanjuan, V; Taminiau, J; Kerwash, E; Khan, D; Musuamba, FT; Skottheim Rusten, I; - view fewer (2017) Commentary on the MID3 good practices paper. CPT: Pharmacometrics & Systems Pharmacology 10.1002/psp4.12223 . (In press). Green open access

http://ift.tt/2tIheZ9